The 20 Best Interstitial Lung Disease Doctors Near Me in Frederick, MD

Dr. Danoff is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine and Co-Director of the Hopkins Interstitial Lung Disease Clinic. She is a specialist in diseases causing fibrosis or scarring in the lung, particularly those associated with autoimmune diseases including myositis. Dr. Danoff is rated as an Elite provider by MediFind in the treatment of Interstitial Lung Disease. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Lung Transplant, and Endoscopy. Dr. Danoff is board certified in American Board Of Internal Medicine.

Dr. McCormack is a pulmonary, critical care physician and Associate Director of the Pulmonary & Critical Care Medicine Division. She is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. She has expertise in pulmonary physiology. She serves as the Medical Director of the Johns Hopkins University Pulmonary Function Laboratory and as the Chair of the American Thoracic Society Pulmonary Function Test Committee. She earned her M.D. from Jefferson Medical College of Thomas Jefferson University and her M.H.S. from the Bloomberg School of Public Health. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. She was the recipient of the Frederick L. Brancati Excellence in Mentoring Award. She plays an active role in mentoring fellows and junior faculty in the Pulmonary & Critical Care Medicine Division. Dr. Mccormack is rated as a Distinguished provider by MediFind in the treatment of Interstitial Lung Disease. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Asthma, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant. Dr. Mccormack is board certified in American Board Of Internal Medicine.

Dr. Neptune is a pulmonary, critical care physician with expertise in genetic disorders of the matrix with pulmonary manifestations. She is also skilled in the management of patients with advanced obstructive lung disease, especially emphysema. Dr. Neptune has extensive expertise in the diagnosis and management of the pulmonary complications of Marfan Syndrome, Loeys-Dietz Syndrome, vascular Ehlers Danlos Syndrome and other matrix disorders and serves on the Professional Advisory Board of the Marfan Foundation. She is also an expert on tobacco dependence and is the Vice-Chair of the Tobacco Action Committee of the American Thoracic Society. Dr. Neptune earned her M.D. from Harvard Medical School. She completed her residency and performed a fellowship in pulmonary and critical care at the University of California, San Francisco. She also performed a fellowship in genetics at Johns Hopkins. Her research interests include therapeutic strategies in Marfan syndrome; mechanisms and prevention of progression of COPD; and hepatocyte growth factor signaling in airspace homeostasis. Dr. Neptune is committed to creating a diverse research community and clinical workforce. She is involved in multiple diversity initiatives at Johns Hopkins and the American Thoracic Society. She is also involved in increasing awareness of tobacco dependence and the needed regulatory policies. Dr. Neptune serves on the Compliance Compensation Subcommittee for the Department of Medicine. Dr. Neptune is rated as a Distinguished provider by MediFind in the treatment of Interstitial Lung Disease. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Acute Interstitial Pneumonia, Interstitial Lung Disease, and Emphysema. Dr. Neptune is board certified in American Board Of Internal Medicine.

Peter Libby is a Neuroradiologist practicing medicine in Salisbury, Maryland. Dr. Libby is rated as a Distinguished provider by MediFind in the treatment of Interstitial Lung Disease. He is also highly rated in 73 other conditions, according to our data. His clinical expertise encompasses Stroke, Bronchogenic Cyst, Gallbladder Disease, Bone Graft, and Vertebroplasty.

Maureen Horton is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Horton is rated as a Distinguished provider by MediFind in the treatment of Interstitial Lung Disease. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Idiopathic Pulmonary Fibrosis.

Nevins Todd is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Todd is rated as a Distinguished provider by MediFind in the treatment of Interstitial Lung Disease. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Pneumonia, Sarcoidosis, and Endoscopy.

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as a Distinguished provider by MediFind in the treatment of Interstitial Lung Disease. He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis. Dr. Wise is board certified in American Board Of Internal Medicine.

Dr. Karthik Suresh is a pulmonary and critical care physician. His clinical interests include acute lung injury and critical care medicine. He also specializes in the diagnosis and management of immune-related lung injury, especially in the context of autoimmune conditions and chemotherapy/immunotherapy for cancer. Dr. Suresh is a member of the Hopkins immune-related adverse events (irAE) tox team. He also takes care of critically ill patients in the medical and oncology ICUs. He’s a firm faculty member for the Janeway Firm of the Osler Housestaff Medical Service and provides teaching to medical students, housestaff and fellows. Dr. Suresh is rated as a Distinguished provider by MediFind in the treatment of Interstitial Lung Disease. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Pneumonia, Interstitial Lung Disease, Acute Interstitial Pneumonia, and Pulmonary Hypertension. Dr. Suresh is board certified in American Board Of Internal Medicine.

Stacey-ann Brown is a Pulmonary Medicine provider practicing medicine in Lutherville, Maryland. Dr. Brown is rated as an Advanced provider by MediFind in the treatment of Interstitial Lung Disease. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Hypersensitivity Pneumonitis, and Cholesterol Pneumonia.

Matthew Lammi, MD MSCR is an Associate Professor of Medicine and part of the Interstitial Lung Disease (ILD) Program. Dr. Lammi obtained his medical degree from Temple University School of Medicine and did his internal medicine, pulmonary, and critical care training at Temple University Hospital. He then joined the faculty at LSU in New Orleans, where he served as the Director of the Comprehensive Pulmonary Hypertension Center. He joined Johns Hopkins in 2023. He currently serves as the Associate Director of the Johns Hopkins Pulmonary Fibrosis Foundation Care Center and is the Associate Program Director for the Advanced Lung Disease Fellowship. His research focuses on the intersection between ILD and pulmonary hypertension, particularly in patients with systemic sclerosis. He is currently a co-Principal Investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is active in numerous societies and serves as the Chair of the Research Committee for the Pulmonary Hypertension Association. Dr. Lammi is rated as an Advanced provider by MediFind in the treatment of Interstitial Lung Disease. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Sarcoidosis, Systemic Sclerosis (SSc), Interstitial Lung Disease, and Lung Transplant. Dr. Lammi is board certified in American Board Of Internal Medicine.

Dr. Cheng Ting Lin is an associate professor of radiology and radiological science at the Johns Hopkins University School of Medicine. His expertise is in diagnostic radiology with particular focus on chest and cardiac imaging. Dr. Cheng Ting Lin received his undergraduate degree from Boston University. He graduated from State University of New York at Stony Brook, where he also completed a radiology residency training program. Dr. Lin completed fellowship training in cardiothoracic imaging at University of Maryland Medical Center. His research interest includes lung cancer screening and diagnosis, chronic obstructive pulmonary disease, Interstitial lung disease, pulmonary embolism, and coronary artery disease. Dr. Lin is rated as an Advanced provider by MediFind in the treatment of Interstitial Lung Disease. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Lung Nodules, Interstitial Lung Disease, Pulmonary Arteriovenous Fistula, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Lin is board certified in American Board Of Radiology.

Stephen C. Mathai, MD, MHS is an Associate Professor of Medicine and part of the Johns Hopkins Pulmonary Hypertension Program. Dr. Mathai received his undergraduate degree from Rutgers College and medical degree from Jefferson Medical College. He pursued residency training in Internal Medicine at Thomas Jefferson University Hospital, where he also served as Chief Medical Resident. Dr. Mathai came to Johns Hopkins for fellowship training in Pulmonary and Critical Care Medicine. During his 5-year fellowship, he obtained a Masters of Health Science degree from the Johns Hopkins Bloomberg School of Public Health and successfully competed for an individual Ruth L. Kirschstein National Research Service Award. Subsequently, he received a K23 award for his research in pulmonary vascular disease in scleroderma. He currently serves as Co-Principal Investigator for the Johns Hopkins PVDOMICS program supported by the NIH and is principal investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is also the Co-Director of the Ann Dana Kusch Multidisciplinary Program for Interstitial Lung Disease and Pulmonary Hypertension. Dr. Mathai has been active in numerous committees and holds several leadership positions in academic societies. He is the current chair of the Pulmonary Vascular Disease Network for the American College of Chest Physicians and has served on the steering committee for this organization for the past 4 years. He has served on several committees for the Pulmonary Circulation Assembly of the American Thoracic Society, including the Program Committee and Nominations Committee. He has organized symposia and delivered presentations related to pulmonary hypertension at numerous international meetings. He is the author of more than 100 publications and has given invited research lectures nationally and internationally. Dr. Mathai is also an active member of patient advocacy organizations. Currently, he is a member of the Scientific Leadership Council of the Pulmonary Hypertension Association where he serves as national chairperson of the Preceptorship Program Planning Committee. He is also a member of the Rare Disease Advisory Panel for the Patient Centered Outcomes Research Institute. Dr. Mathai also serves as the faculty leader of the inpatient pulmonary service, the Carol Johns Service, where he is responsible for the education of the internal medicine housestaff and pulmonary fellows. He has also received the Frederick L. Brancati Award for mentorship from the Department of Medicine at Johns Hopkins. Dr. Mathai is rated as an Advanced provider by MediFind in the treatment of Interstitial Lung Disease. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Systemic Sclerosis (SSc), Pulmonary Veno-Occlusive Disease, Sarcoidosis, and Lung Transplant. Dr. Mathai is board certified in American Board Of Internal Medicine.

David Holden, M.D., practices pulmonary medicine at Johns Hopkins Community Physicians Pulmonology & Sleep Medicine. He received his medical degree from the University Of Cincinnati College Of Medicine, and also completed his residency in internal medicine at the Cleveland Clinic. Dr. Holden is rated as an Advanced provider by MediFind in the treatment of Interstitial Lung Disease. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Lung Metastases, Pneumonia, and Interstitial Lung Disease. Dr. Holden is board certified in American Board Of Internal Medicine.

Dr. Fessler is a specialist in Pulmonary and Critical Care Medicine. He is an expert in the diagnosis and management of acute respiratory failure, including asthma, pneumonia, C.O.P.D., neuromuscular diseases, and the acute respiratory distress syndrome. He also has extensive experience in the management of other life-threatening conditions such as gastrointestinal bleeding, pulmonary embolism, diabetic ketoacidosis and hyperosmolar states, and shock. Dr. Fessler is rated as an Advanced provider by MediFind in the treatment of Interstitial Lung Disease. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Secondary Immunodeficiency (SID), Cystic Fibrosis, Acute Interstitial Pneumonia, and Interstitial Lung Disease. Dr. Fessler is board certified in American Board Of Internal Medicine.

Anna Gersten is a Pulmonary Medicine provider practicing medicine in Baltimore, Maryland. Dr. Gersten is rated as an Advanced provider by MediFind in the treatment of Interstitial Lung Disease. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, and Lung Metastases. Dr. Gersten is board certified in American Board Of Internal Medicine.

Dr. Merlo is an internist who specializes in pulmonary and critical care medicine. Dr. Merlo also has clinical expertise in the care of patients with cystic fibrosis as well as clinical expertise in the care of patients with advanced lung disease who may require or have undergone lung transplantation. Dr. Merlo holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Merlo attended the College of the Holy Cross and completed medical school and residency training in internal medicine at Georgetown University. He completed both clinical and research fellowships in pulmonary and critical care medicine at Johns Hopkins, and earned his M.P.H. at the Bloomberg School of Public Health. His research interests include outcomes in lung transplantation and cystic fibrosis, HIV-related pulmonary disease, and outcomes in Osler Weber Rendu. Dr. Merlo serves as the Associate Program Director of Scholarship for the Osler Medical Housestaff Training Program. He has contributed numerous scientific papers and book chapters related to cystic fibrosis and lung transplantation, and his awards include the Harry Shwachman Clinical Investigator Award from the Cystic Fibrosis Foundation. Dr. Merlo is rated as an Advanced provider by MediFind in the treatment of Interstitial Lung Disease. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Secondary Immunodeficiency (SID), Aspergillosis, Lung Transplant, and Endoscopy.

George Reeder is a Pulmonary Medicine provider practicing medicine in Salisbury, Maryland. Dr. Reeder is rated as a Distinguished provider by MediFind in the treatment of Interstitial Lung Disease. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Acute Interstitial Pneumonia, and Interstitial Lung Disease.

Bernadette Gochuico is a Pulmonary Medicine provider practicing medicine in Bethesda, Maryland. Dr. Gochuico is rated as a Distinguished provider by MediFind in the treatment of Interstitial Lung Disease. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Pulmonary Fibrosis, Interstitial Lung Disease, Acute Interstitial Pneumonia, and Idiopathic Pulmonary Fibrosis.

Nirav Shah is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Interstitial Lung Disease. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Sarcoidosis, Endoscopy, and Gastrostomy.

Albert Polito is an Intensive Care Medicine provider practicing medicine in Baltimore, Maryland. Dr. Polito is rated as an Advanced provider by MediFind in the treatment of Interstitial Lung Disease. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease, and Acute Interstitial Pneumonia.